NCT06945419View on ClinicalTrials.gov

A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes

PHASE1RecruitingINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

April 23, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
HealthyOverweightObesityType 2 Diabetes
Interventions
DRUG

LY4086940

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (4)

32117

ACTIVE_NOT_RECRUITING

Fortrea Clinical Research Unit, Daytona Beach

75247

RECRUITING

Fortrea Clinical Research Unit, Dallas

78240

RECRUITING

Endeavor Clinical Trials, San Antonio

138623

COMPLETED

Lilly Centre for Clinical Pharmacology, Singapore

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY